Charting New Waters in Women’s Bleeding Disorders Care

A session led by Dawn Rotellini at the National Bleeding Disorders Conference this past summer, spotlighted inclusive care for women with bleeding disorders, introducing the WGPPM concept and emphasizing access to treatment, education, and stigma reduction as key areas for advancing women’s health.

At the Bleeding Disorders Conference, a pioneering session led by Dawn Rotellini of the National Bleeding Disorders Foundation put women’s health in the spotlight. The panel introduced a game-changing concept: WGPPM (Women, Girls, and People with Potential to Menstruate), signaling a shift towards more inclusive care.

Experts, ranging from pharmaceutical leaders to those with lived experiences, outlined three crucial focus areas: enhancing treatment access, amplifying awareness and education, and dismantling stigma. These pillars form the bedrock of a reimagined care strategy for women with bleeding disorders.

Carrie Funkhouser from the Foundation for Women and Girls with Blood Disorders unveiled innovative initiatives, including professional education programs and a comprehensive menstruation toolkit. These resources aim to empower healthcare providers with the knowledge to navigate the unique challenges of women’s bleeding disorders.

The session concluded with a clear and optimistic outlook for the future of women’s bleeding disorder care. Experts emphasized that ongoing research and open dialogue are driving significant improvements in treatment and understanding. 

Rotellini stated, “We’re witnessing a paradigm shift in how the medical community approaches women’s bleeding disorders. With continued effort and collaboration, we can ensure that every patient receives the comprehensive care they deserve.” 

This renewed focus on women’s health in bleeding disorders represents a major step forward in addressing a long-overlooked aspect of hematology. As awareness grows and new treatments emerge, patients and healthcare providers alike are looking forward to a future where these conditions are better understood and more effectively managed.

Source: National Bleeding Disorders Foundation, September 2024